Clinical Research in Primary Hypersomnias

We are evaluating the safety and efficacy of an investigational drug product to address symptoms experienced by subjects with sleep disorders such as Idiopathic Hypersomnia and Narcolepsy without cataplexy. These symptoms include excessive daytime sleepiness, pervasive tiredness and fatigue. We are conducting a clinical study ARISE 201 for subjects with Idiopathic Hypersomnia and Narcolepsy without cataplexy age 18 and older to evaluate this product. The study is currently enrolling at clinical study sites across the United States.

If you are interested in participating in our current clinical study, please click here.

Find out if you are eligible to participate in the current study by filling out the “See If You Qualify” questionnaire.